These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

83 related articles for article (PubMed ID: 10939840)

  • 1. Clues to the cause of neurodegeneration.
    Evans KL
    Mol Med Today; 2000 Jun; 6(6):219. PubMed ID: 10939840
    [No Abstract]   [Full Text] [Related]  

  • 2. Down the ataxin-1 track.
    López JC
    Nat Rev Neurosci; 2000 Dec; 1(3):154. PubMed ID: 11257899
    [No Abstract]   [Full Text] [Related]  

  • 3. Neurodegeneration: a question of balance.
    Thompson LM
    Nature; 2008 Apr; 452(7188):707-8. PubMed ID: 18401401
    [No Abstract]   [Full Text] [Related]  

  • 4. Hereditary ataxia. An unfolded protein.
    Orr HT
    Lancet; 2001 Dec; 358 Suppl():S35. PubMed ID: 11784584
    [No Abstract]   [Full Text] [Related]  

  • 5. Amino acids in a region of ataxin-1 outside of the polyglutamine tract influence the course of disease in SCA1 transgenic mice.
    Skinner PJ; Vierra-Green CA; Emamian E; Zoghbi HY; Orr HT
    Neuromolecular Med; 2002; 1(1):33-42. PubMed ID: 12025814
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Interaction of Akt-phosphorylated ataxin-1 with 14-3-3 mediates neurodegeneration in spinocerebellar ataxia type 1.
    Chen HK; Fernandez-Funez P; Acevedo SF; Lam YC; Kaytor MD; Fernandez MH; Aitken A; Skoulakis EM; Orr HT; Botas J; Zoghbi HY
    Cell; 2003 May; 113(4):457-68. PubMed ID: 12757707
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tissue transglutaminase crosslinks ataxin-1: possible role in SCA1 pathogenesis.
    D'Souza DR; Wei J; Shao Q; Hebert MD; Subramony SH; Vig PJ
    Neurosci Lett; 2006 Nov; 409(1):5-9. PubMed ID: 17045396
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Recovery from polyglutamine-induced neurodegeneration in conditional SCA1 transgenic mice.
    Zu T; Duvick LA; Kaytor MD; Berlinger MS; Zoghbi HY; Clark HB; Orr HT
    J Neurosci; 2004 Oct; 24(40):8853-61. PubMed ID: 15470152
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Serine 776 of ataxin-1 is critical for polyglutamine-induced disease in SCA1 transgenic mice.
    Emamian ES; Kaytor MD; Duvick LA; Zu T; Tousey SK; Zoghbi HY; Clark HB; Orr HT
    Neuron; 2003 May; 38(3):375-87. PubMed ID: 12741986
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Early impairment in brain metabolism detected by MR spectroscopy antedates structural changes in mouse models of spinocerebellar ataxias.
    Mlynárik V; McKenna MC
    J Neurochem; 2013 Dec; 127(5):578-9. PubMed ID: 24147560
    [No Abstract]   [Full Text] [Related]  

  • 11. The AXH domain of Ataxin-1 mediates neurodegeneration through its interaction with Gfi-1/Senseless proteins.
    Tsuda H; Jafar-Nejad H; Patel AJ; Sun Y; Chen HK; Rose MF; Venken KJ; Botas J; Orr HT; Bellen HJ; Zoghbi HY
    Cell; 2005 Aug; 122(4):633-44. PubMed ID: 16122429
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pigmentary macular dystrophy in spinocerebellar ataxia type 1.
    Saito Y; Matsumura K; Shimizu S; Ichikawa Y; Ochiai K; Goto J; Tsuji S; Shimizu T
    J Neurol Neurosurg Psychiatry; 2006 Nov; 77(11):1293. PubMed ID: 17043301
    [No Abstract]   [Full Text] [Related]  

  • 13. A case of amyotrophic lateral sclerosis with intermediate ATXN-1 CAG repeat expansion in a large family with spinocerebellar ataxia type 1.
    Spataro R; La Bella V
    J Neurol; 2014 Jul; 261(7):1442-3. PubMed ID: 24916831
    [No Abstract]   [Full Text] [Related]  

  • 14. Toward cell specificity in SCA1.
    Humbert S; Saudou F
    Neuron; 2002 May; 34(5):669-70. PubMed ID: 12062012
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hereditary ataxias.
    Evidente VG; Gwinn-Hardy KA; Caviness JN; Gilman S
    Mayo Clin Proc; 2000 May; 75(5):475-90. PubMed ID: 10807077
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Relationship between ataxin-1 nuclear inclusions and Purkinje cell specific proteins in SCA-1 transgenic mice.
    Vig PJ; Subramony SH; Qin Z; McDaniel DO; Fratkin JD
    J Neurol Sci; 2000 Mar; 174(2):100-10. PubMed ID: 10727695
    [TBL] [Abstract][Full Text] [Related]  

  • 17. SCA1 molecular genetics: a history of a 13 year collaboration against glutamines.
    Orr HT; Zoghbi HY
    Hum Mol Genet; 2001 Oct; 10(20):2307-11. PubMed ID: 11673415
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In vivo monitoring of recovery from neurodegeneration in conditional transgenic SCA1 mice.
    Oz G; Vollmers ML; Nelson CD; Shanley R; Eberly LE; Orr HT; Clark HB
    Exp Neurol; 2011 Dec; 232(2):290-8. PubMed ID: 21963649
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Noninvasive detection of presymptomatic and progressive neurodegeneration in a mouse model of spinocerebellar ataxia type 1.
    Oz G; Nelson CD; Koski DM; Henry PG; Marjanska M; Deelchand DK; Shanley R; Eberly LE; Orr HT; Clark HB
    J Neurosci; 2010 Mar; 30(10):3831-8. PubMed ID: 20220018
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A genetic epidemiological study of spinocerebellar ataxias in Tottori prefecture, Japan.
    Mori M; Adachi Y; Kusumi M; Nakashima K
    Neuroepidemiology; 2001 May; 20(2):144-9. PubMed ID: 11359084
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.